Paulson & Co. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$86,323,000
-58.0%
4,727,415
-58.1%
1.98%
-62.9%
Q4 2020$205,584,000
+2.0%
11,295,8460.0%5.34%
-15.0%
Q3 2020$201,518,000
-2.2%
11,295,846
-1.7%
6.28%
-4.6%
Q2 2020$205,960,000
+2.4%
11,486,905
-13.3%
6.58%
-14.2%
Q1 2020$201,055,000
-23.1%
13,244,7110.0%7.67%
+36.0%
Q4 2019$261,318,000
+14.7%
13,244,7110.0%5.64%
+23.7%
Q3 2019$227,809,000
-2.8%
13,244,7110.0%4.56%
+14.5%
Q2 2019$234,431,000
-56.6%
13,244,711
-50.0%
3.98%
-30.9%
Q1 2019$539,590,00026,489,4225.77%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders